{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:04:20Z","timestamp":1790251460467,"version":"4.1.0"},"publisher-location":"Cham","reference-count":163,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319237299","type":"print"},{"value":"9783319237305","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-23730-5_11","type":"book-chapter","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T15:56:26Z","timestamp":1449849386000},"page":"201-230","source":"Crossref","is-referenced-by-count":51,"title":["microRNA and Bone Cancer"],"prefix":"10.1007","author":[{"given":"Mary","family":"Nugent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"11_CR1","first-page":"121","volume":"10","author":"T Ibrahim","year":"2013","unstructured":"Ibrahim T, Mercatali L, Amadori D. Bone and cancer: the osteoncology. Clin Cases Miner Bone Metab. 2013;10(2):121\u20133.","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"5","key":"11_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843\u201354.","journal-title":"Cell"},{"key":"11_CR3","unstructured":"miRBase 21. Manchester: University of Manchester; 2014. http:\/\/www.mirbase.org\/index.shtml. Accessed June 2014 to 22nd Dec 2014"},{"issue":"Database issue","key":"11_CR4","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkh023","volume":"32","author":"S Griffiths-Jones","year":"2004","unstructured":"Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004;32(Database issue):D109\u201311.","journal-title":"Nucleic Acids Res"},{"key":"11_CR5","first-page":"129","volume":"342","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones S. miRBase: the microRNA sequence database. Methods Mol Biol. 2006;342:129\u201338.","journal-title":"Methods Mol Biol"},{"issue":"Database issue","key":"11_CR6","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gkj112","volume":"34","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(Database issue):D140\u20134.","journal-title":"Nucleic Acids Res"},{"key":"11_CR7","doi-asserted-by":"crossref","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39(Database issue):D152\u20137.","DOI":"10.1093\/nar\/gkq1027"},{"key":"11_CR8","doi-asserted-by":"crossref","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42(Database issue):D68\u201373.","DOI":"10.1093\/nar\/gkt1181"},{"issue":"7","key":"11_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522\u201331.","journal-title":"Nat Rev Genet"},{"key":"11_CR10","doi-asserted-by":"crossref","unstructured":"Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006;20(5):515\u201324.","DOI":"10.1101\/gad.1399806"},{"issue":"2","key":"11_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"key":"11_CR12","doi-asserted-by":"crossref","unstructured":"Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11(3):228\u201334.","DOI":"10.1038\/ncb0309-228"},{"issue":"2","key":"11_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/35052556","volume":"2","author":"SM Hammond","year":"2001","unstructured":"Hammond SM, Caudy AA, Hannon GJ. Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet. 2001;2(2):110\u20139.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"11_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejso.2008.06.006","volume":"35","author":"AH Mirnezami","year":"2009","unstructured":"Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol. 2009;35(4):339\u201347.","journal-title":"Eur J Surg Oncol"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/CMAR.S53928","volume":"6","author":"M Nugent","year":"2014","unstructured":"Nugent M. MicroRNA function and dysregulation in bone tumors: the evidence to date. Cancer Manag Res. 2014;6:15\u201325.","journal-title":"Cancer Manag Res"},{"issue":"13","key":"11_CR16","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1093\/hmg\/dds129","volume":"21","author":"Y Bae","year":"2012","unstructured":"Bae Y, Yang T, Zeng HC, Campeau PM, Chen Y, Bertin T, et al. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet. 2012;21(13):2991\u20133000.","journal-title":"Hum Mol Genet"},{"issue":"7515","key":"11_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13375","volume":"512","author":"JY Krzeszinski","year":"2014","unstructured":"Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature. 2014;512(7515):431\u20135.","journal-title":"Nature"},{"issue":"1","key":"11_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14348\/molcells.2015.2241","volume":"38","author":"K Kim","year":"2015","unstructured":"Kim K, Kim JH, Kim I, Lee J, Seong S, Park YW, et al. MicroRNA-26a Regulates RANKL-Induced Osteoclast Formation. Mol Cells. 2015;38(1):75\u201380.","journal-title":"Mol Cells"},{"issue":"37","key":"11_CR19","doi-asserted-by":"publisher","first-page":"13906","DOI":"10.1073\/pnas.0804438105","volume":"105","author":"Z Li","year":"2008","unstructured":"Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A. 2008;105(37):13906\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"e1050","DOI":"10.1038\/cddis.2014.4","volume":"5","author":"J Kureel","year":"2014","unstructured":"Kureel J, Dixit M, Tyagi AM, Mansoori MN, Srivastava K, Raghuvanshi A, et al. miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation. Cell Death Dis. 2014;5:e1050.","journal-title":"Cell Death Dis"},{"issue":"4","key":"11_CR21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.22757","volume":"49","author":"S Li","year":"2009","unstructured":"Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J, et al. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology. 2009;49(4):1194\u2013202.","journal-title":"Hepatology"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1476-4598-8-102","volume":"8","author":"O Slaby","year":"2009","unstructured":"Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer. 2009;8:102.","journal-title":"Mol Cancer"},{"issue":"8","key":"11_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.biocel.2009.05.018","volume":"42","author":"S Rossi","year":"2010","unstructured":"Rossi S, Kopetz S, Davuluri R, Hamilton SR, Calin GA. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol. 2010;42(8):1291\u20137.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"11_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/bjs.5673","volume":"94","author":"BP Wijnhoven","year":"2007","unstructured":"Wijnhoven BP, Michael MZ, Watson DI. MicroRNAs and cancer. Br J Surg. 2007;94(1):23\u201330.","journal-title":"Br J Surg"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"359739","DOI":"10.1155\/2012\/359739","volume":"2012","author":"E Kobayashi","year":"2012","unstructured":"Kobayashi E, Hornicek FJ, Duan Z. MicroRNA involvement in osteosarcoma. Sarcoma. 2012;2012:359739.","journal-title":"Sarcoma"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","volume":"152","author":"G Ottaviani","year":"2009","unstructured":"Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3\u201313.","journal-title":"Cancer Treat Res"},{"issue":"9","key":"11_CR27","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s11999-008-0335-z","volume":"466","author":"N Tang","year":"2008","unstructured":"Tang N, Song WX, Luo J, Haydon RC, He TC. Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res. 2008;466(9):2114\u201330.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"11_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1200\/JCO.20.3.776","volume":"20","author":"SS Bielack","year":"2002","unstructured":"Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20(3):776\u201390.","journal-title":"J Clin Oncol"},{"issue":"10","key":"11_CR29","first-page":"705","volume":"8","author":"DS Geller","year":"2010","unstructured":"Geller DS, Gorlick R. Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol. 2010;8(10):705\u201318.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"11_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2008.09.030","volume":"279","author":"Z Wang","year":"2009","unstructured":"Wang Z, Li Y, Banerjee S, Sarkar FH. Emerging role of Notch in stem cells and cancer. Cancer Lett. 2009;279(1):8\u201312.","journal-title":"Cancer Lett"},{"issue":"2","key":"11_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2009.11.012","volume":"292","author":"Z Wang","year":"2010","unstructured":"Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett. 2010;292(2):141\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"11_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2009.07.101","volume":"388","author":"C He","year":"2009","unstructured":"He C, Xiong J, Xu X, Lu W, Liu L, Xiao D, et al. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun. 2009;388(1):35\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"11_CR33","doi-asserted-by":"crossref","unstructured":"He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447(7148):1130\u20134.","DOI":"10.1038\/nature05939"},{"key":"11_CR34","doi-asserted-by":"crossref","unstructured":"Li J, Liu W, Zhao K, Zhang Y, Li X, Yang Q, et al. Diallyl trisulfide reverses drug resistance and lowers the ratio of CD133+ cells in conjunction with methotrexate in a human osteosarcoma drug-resistant cell subline. Mol Med Rep. 2009;2(2):245\u201352.","DOI":"10.3892\/mmr_00000091"},{"issue":"7","key":"11_CR35","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/carcin\/bgt065","volume":"34","author":"Y Li","year":"2013","unstructured":"Li Y, Zhang J, Zhang L, Si M, Yin H, Li J. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Carcinogenesis. 2013;34(7):1601\u201310.","journal-title":"Carcinogenesis"},{"key":"11_CR36","doi-asserted-by":"crossref","unstructured":"Song L, Yang J, Duan P, Xu J, Luo X, Luo F, et al. MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATbeta. Arch Biochem Biophys. 2013;535(2):128\u201335.","DOI":"10.1016\/j.abb.2013.04.001"},{"key":"11_CR37","doi-asserted-by":"crossref","unstructured":"Annunziata M, Granata R, Ghigo E. The IGF system. Acta Diabetol. 2011;48(1):1\u20139.","DOI":"10.1007\/s00592-010-0227-z"},{"issue":"9","key":"11_CR38","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.febslet.2013.03.007","volume":"587","author":"L Chen","year":"2013","unstructured":"Chen L, Wang Q, Wang GD, Wang HS, Huang Y, Liu XM, et al. miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1\/2-ERK1\/2 pathway in osteosarcoma. FEBS Lett. 2013;587(9):1366\u201372.","journal-title":"FEBS Lett"},{"issue":"3","key":"11_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cancergen.2010.12.012","volume":"204","author":"G Maire","year":"2011","unstructured":"Maire G, Martin JW, Yoshimoto M, Chilton-MacNeill S, Zielenska M, Squire JA. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. Cancer Genet. 2011;204(3):138\u201346.","journal-title":"Cancer Genet"},{"issue":"1","key":"11_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bone.2011.10.012","volume":"50","author":"V Thayanithy","year":"2012","unstructured":"Thayanithy V, Sarver AL, Kartha RV, Li L, Angstadt AY, Breen M, et al. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone. 2012;50(1):171\u201381.","journal-title":"Bone"},{"issue":"2","key":"11_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/138920210790886853","volume":"11","author":"J Xiang","year":"2010","unstructured":"Xiang J, Wu J. Feud or friend? The role of the miR-17-92 cluster in tumorigenesis. Curr Genomics. 2010;11(2):129\u201335.","journal-title":"Curr Genomics"},{"issue":"2","key":"11_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12020-013-9986-y","volume":"45","author":"M Zhou","year":"2014","unstructured":"Zhou M, Ma J, Chen S, Chen X, Yu X. MicroRNA-17-92 cluster regulates osteoblast proliferation and differentiation. Endocrine. 2014;45(2):302\u201310.","journal-title":"Endocrine"},{"issue":"1\u20132","key":"11_CR43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.18632\/genesandcancer.6","volume":"5","author":"L Arabi","year":"2014","unstructured":"Arabi L, Gsponer JR, Smida J, Nathrath M, Perrina V, Jundt G, et al. Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma\u2014reasons and consequences. Genes Cancer. 2014;5(1\u20132):56\u201363.","journal-title":"Genes Cancer"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1477-7819-12-195","volume":"12","author":"SH Xu","year":"2014","unstructured":"Xu SH, Yang YL, Han SM, Wu ZH. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma. World J Surg Oncol. 2014;12:195.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"11_CR45","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s12032-010-9563-7","volume":"28","author":"W Ziyan","year":"2011","unstructured":"Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol. 2011;28(4):1469\u201374.","journal-title":"Med Oncol"},{"issue":"1","key":"11_CR46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12032-012-0340-7","volume":"30","author":"L Ouyang","year":"2013","unstructured":"Ouyang L, Liu P, Yang S, Ye S, Xu W, Liu X. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med Oncol. 2013;30(1):340.","journal-title":"Med Oncol"},{"issue":"1","key":"11_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13402-011-0059-z","volume":"35","author":"L Montanini","year":"2012","unstructured":"Montanini L, Lasagna L, Barili V, Jonstrup SP, Murgia A, Pazzaglia L, et al. MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93. Cell Oncol (Dordr). 2012;35(1):29\u201341.","journal-title":"Cell Oncol (Dordr)"},{"key":"11_CR48","first-page":"1601","volume":"7","author":"Z Tian","year":"2014","unstructured":"Tian Z, Guo B, Yu M, Wang C, Zhang H, Liang Q, et al. Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTEN confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma. Onco Targets Ther. 2014;7:1601\u20138.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"11_CR49","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/bjc.2013.549","volume":"109","author":"SU Lauvrak","year":"2013","unstructured":"Lauvrak SU, Munthe E, Kresse SH, Stratford EW, Namlos HM, Meza-Zepeda LA, et al. Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer. 2013;109(8):2228\u201336.","journal-title":"Br J Cancer"},{"key":"11_CR50","doi-asserted-by":"publisher","first-page":"732690","DOI":"10.1155\/2011\/732690","volume":"2011","author":"RR Lulla","year":"2011","unstructured":"Lulla RR, Costa FF, Bischof JM, Chou PM, de F Bonaldo M, Vanin EF, et al. Identification of differentially expressed microRNAs in osteosarcoma. Sarcoma. 2011;2011:732690.","journal-title":"Sarcoma"},{"issue":"7","key":"11_CR51","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1158\/0008-5472.CAN-11-2663","volume":"72","author":"KB Jones","year":"2012","unstructured":"Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 2012;72(7):1865\u201377.","journal-title":"Cancer Res"},{"issue":"8","key":"11_CR52","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.humpath.2013.01.016","volume":"44","author":"KY Won","year":"2013","unstructured":"Won KY, Kim YW, Kim HS, Lee SK, Jung WW, Park YK. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma. Hum Pathol. 2013;44(8):1648\u201355.","journal-title":"Hum Pathol"},{"issue":"2","key":"11_CR53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s12032-013-0499-6","volume":"30","author":"H Cai","year":"2013","unstructured":"Cai H, Lin L, Tang M, Wang Z. Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma. Med Oncol. 2013;30(2):499.","journal-title":"Med Oncol"},{"issue":"2","key":"11_CR54","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbrc.2014.04.140","volume":"449","author":"Z Xu","year":"2014","unstructured":"Xu Z, Wang T. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1. Biochem Biophys Res Commun. 2014;449(2):190\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"11_CR55","doi-asserted-by":"publisher","first-page":"e53906","DOI":"10.1371\/journal.pone.0053906","volume":"8","author":"G Zhao","year":"2013","unstructured":"Zhao G, Cai C, Yang T, Qiu X, Liao B, Li W, et al. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K\/Akt pathway in human osteosarcoma. PLoS One. 2013;8(1):e53906.","journal-title":"PLoS One"},{"issue":"4","key":"11_CR56","first-page":"622","volume":"46","author":"W Zhang","year":"2012","unstructured":"Zhang W, Qian JX, Yi HL, Yang ZD, Wang CF, Chen JY, et al. The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression. Mol Biol (Mosk). 2012;46(4):622\u20137.","journal-title":"Mol Biol (Mosk)"},{"issue":"9","key":"11_CR57","first-page":"5701","volume":"7","author":"K Zhang","year":"2014","unstructured":"Zhang K, Zhang C, Liu L, Zhou J. A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and migration via modulation of VEGF. Int J Clin Exp Pathol. 2014;7(9):5701\u20138.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"11_CR58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.gene.2013.06.021","volume":"527","author":"SR Baglio","year":"2013","unstructured":"Baglio SR, Devescovi V, Granchi D, Baldini N. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene. 2013;527(1):321\u201331.","journal-title":"Gene"},{"key":"11_CR59","doi-asserted-by":"crossref","unstructured":"Tian Y, Zhang YZ, Chen W. MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells. Biosci Rep. 2014;34(4).","DOI":"10.1042\/BSR20140084"},{"issue":"3","key":"11_CR60","doi-asserted-by":"publisher","first-page":"e33778","DOI":"10.1371\/journal.pone.0033778","volume":"7","author":"K Yan","year":"2012","unstructured":"Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q, et al. MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One. 2012;7(3):e33778.","journal-title":"PLoS One"},{"issue":"1","key":"11_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejso.2013.08.024","volume":"40","author":"Q Tian","year":"2014","unstructured":"Tian Q, Jia J, Ling S, Liu Y, Yang S, Shao Z. A causal role for circulating miR-34b in osteosarcoma. Eur J Surg Oncol. 2014;40(1):67\u201372.","journal-title":"Eur J Surg Oncol"},{"issue":"29","key":"11_CR62","doi-asserted-by":"publisher","first-page":"21307","DOI":"10.1074\/jbc.M112.445890","volume":"288","author":"M van der Deen","year":"2013","unstructured":"van der Deen M, Taipaleenmaki H, Zhang Y, Teplyuk NM, Gupta A, Cinghu S, et al. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. J Biol Chem. 2013;288(29):21307\u201319.","journal-title":"J Biol Chem"},{"issue":"6","key":"11_CR63","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s11596-014-1369-y","volume":"34","author":"S Lin","year":"2014","unstructured":"Lin S, Shao NN, Fan L, Ma XC, Pu FF, Shao ZW. Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR. J Huazhong Univ Sci Technolog Med Sci. 2014;34(6):889\u201395.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"1\u20132","key":"11_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2011.10.117","volume":"416","author":"LH Liu","year":"2011","unstructured":"Liu LH, Li H, Li JP, Zhong H, Zhang HC, Chen J, et al. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. Biochem Biophys Res Commun. 2011;416(1\u20132):31\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"11_CR65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/ijms15010423","volume":"15","author":"C Yang","year":"2014","unstructured":"Yang C, Hou C, Zhang H, Wang D, Ma Y, Zhang Y, et al. miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2. Int J Mol Sci. 2014;15(1):423\u201337.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11_CR66","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/CCO.0b013e3283622c1b","volume":"25","author":"J Yang","year":"2013","unstructured":"Yang J, Zhang W. New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol. 2013;25(4):398\u2013406.","journal-title":"Curr Opin Oncol"},{"issue":"1\u20132","key":"11_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11010-013-1677-8","volume":"381","author":"J Yang","year":"2013","unstructured":"Yang J, Gao T, Tang J, Cai H, Lin L, Fu S. Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma. Mol Cell Biochem. 2013;381(1\u20132):9\u201315.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"11_CR68","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bone.2013.05.020","volume":"56","author":"F Ji","year":"2013","unstructured":"Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, et al. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 2013;56(1):220\u20136.","journal-title":"Bone"},{"issue":"12","key":"11_CR69","doi-asserted-by":"publisher","first-page":"e83571","DOI":"10.1371\/journal.pone.0083571","volume":"8","author":"H Zhao","year":"2013","unstructured":"Zhao H, Li M, Li L, Yang X, Lan G, Zhang Y. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One. 2013;8(12):e83571.","journal-title":"PLoS One"},{"issue":"7","key":"11_CR70","doi-asserted-by":"publisher","first-page":"e102621","DOI":"10.1371\/journal.pone.0102621","volume":"9","author":"Z Liu","year":"2014","unstructured":"Liu Z, Zhang G, Li J, Liu J, Lv P. The tumor-suppressive microRNA-135b targets c-myc in osteosarcoma. PLoS One. 2014;9(7):e102621.","journal-title":"PLoS One"},{"key":"11_CR71","first-page":"833","volume":"6","author":"M Tang","year":"2013","unstructured":"Tang M, Lin L, Cai H, Tang J, Zhou Z. MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma. Onco Targets Ther. 2013;6:833\u20138.","journal-title":"Onco Targets Ther"},{"issue":"6","key":"11_CR72","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.ajpath.2012.02.023","volume":"180","author":"J Zhu","year":"2012","unstructured":"Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X, et al. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol. 2012;180(6):2440\u201351.","journal-title":"Am J Pathol"},{"issue":"8","key":"11_CR73","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1158\/1535-7163.MCT-11-0096","volume":"10","author":"Z Duan","year":"2011","unstructured":"Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, et al. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther. 2011;10(8):1337\u201345.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"11_CR74","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.7314\/APJCP.2013.14.6.3751","volume":"14","author":"YP Bao","year":"2013","unstructured":"Bao YP, Yi Y, Peng LL, Fang J, Liu KB, Li WZ, et al. Roles of microRNA-206 in osteosarcoma pathogenesis and progression. Asian Pac J Cancer Prev. 2013;14(6):3751\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"11_CR75","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.humpath.2014.02.018","volume":"45","author":"H Zhang","year":"2014","unstructured":"Zhang H, Yin Z, Ning K, Wang L, Guo R, Ji Z. Prognostic value of microRNA-223\/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. Hum Pathol. 2014;45(7):1430\u20136.","journal-title":"Hum Pathol"},{"issue":"5","key":"11_CR76","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1007\/s13277-013-1546-9","volume":"35","author":"C Cheng","year":"2014","unstructured":"Cheng C, Chen ZQ, Shi XT. MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase. Tumour Biol. 2014;35(5):4177\u201383.","journal-title":"Tumour Biol"},{"issue":"1\u20132","key":"11_CR77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11010-013-1786-4","volume":"384","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhao W, Fu Q. miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem. 2013;384(1\u20132):105\u201311.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"11_CR78","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bbrc.2013.07.033","volume":"437","author":"X Zhou","year":"2013","unstructured":"Zhou X, Wei M, Wang W. MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. Biochem Biophys Res Commun. 2013;437(4):653\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"11_CR79","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3892\/etm.2013.959","volume":"5","author":"XH Long","year":"2013","unstructured":"Long XH, Mao JH, Peng AF, Zhou Y, Huang SH, Liu ZL. Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med. 2013;5(4):1048\u201352.","journal-title":"Exp Ther Med"},{"issue":"1","key":"11_CR80","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12032-014-0324-x","volume":"32","author":"J Yuan","year":"2015","unstructured":"Yuan J, Lang J, Liu C, Zhou K, Chen L, Liu Y. The expression and function of miRNA-451 in osteosarcoma. Med Oncol. 2015;32(1):324.","journal-title":"Med Oncol"},{"issue":"10","key":"11_CR81","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","volume":"21","author":"L Kager","year":"2003","unstructured":"Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003;21(10):2011\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"11_CR82","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1200\/JCO.2005.04.063","volume":"23","author":"B Kempf-Bielack","year":"2005","unstructured":"Kempf-Bielack B, Bielack SS, Jurgens H, Branscheid D, Berdel WE, Exner GU, et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005;23(3):559\u201368.","journal-title":"J Clin Oncol"},{"issue":"6","key":"11_CR83","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/jso.21140","volume":"98","author":"G Bacci","year":"2008","unstructured":"Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, et al. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008;98(6):415\u201320.","journal-title":"J Surg Oncol"},{"issue":"23","key":"11_CR84","doi-asserted-by":"publisher","first-page":"8114","DOI":"10.1158\/1078-0432.CCR-04-0353","volume":"10","author":"EA Lafleur","year":"2004","unstructured":"Lafleur EA, Koshkina NV, Stewart J, Jia SF, Worth LL, Duan X, et al. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells. Clin Cancer Res. 2004;10(23):8114\u20139.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"11_CR85","first-page":"823","volume":"9","author":"LL Worth","year":"2002","unstructured":"Worth LL, Lafleur EA, Jia SF, Kleinerman ES. Fas expression inversely correlates with metastatic potential in osteosarcoma cells. Oncol Rep. 2002;9(4):823\u20137.","journal-title":"Oncol Rep"},{"issue":"4","key":"11_CR86","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1158\/0008-5472.CAN-11-1460","volume":"72","author":"G Huang","year":"2012","unstructured":"Huang G, Nishimoto K, Zhou Z, Hughes D, Kleinerman ES. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res. 2012;72(4):908\u201316.","journal-title":"Cancer Res"},{"issue":"6","key":"11_CR87","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/mt.2011.53","volume":"19","author":"M Osaki","year":"2011","unstructured":"Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, Yoshioka Y, et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther. 2011;19(6):1123\u201330.","journal-title":"Mol Ther"},{"issue":"4","key":"11_CR88","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/10409238.2013.786671","volume":"48","author":"AV Schofield","year":"2013","unstructured":"Schofield AV, Bernard O. Rho-associated coiled-coil kinase (ROCK) signaling and disease. Crit Rev Biochem Mol Biol. 2013;48(4):301\u201316.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"11_CR89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3892\/mmr.2014.2195","volume":"10","author":"P Lei","year":"2014","unstructured":"Lei P, Xie J, Wang L, Yang X, Dai Z, Hu Y. microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1. Mol Med Rep. 2014;10(1):155\u201360.","journal-title":"Mol Med Rep"},{"issue":"1","key":"11_CR90","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/ijms15010560","volume":"15","author":"H Cai","year":"2014","unstructured":"Cai H, Lin L, Tang M, Wang Z. Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma. Int J Mol Sci. 2014;15(1):560\u201373.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11_CR91","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3892\/or.2014.2989","volume":"31","author":"QC Song","year":"2014","unstructured":"Song QC, Shi ZB, Zhang YT, Ji L, Wang KZ, Duan DP, et al. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients. Oncol Rep. 2014;31(3):1263\u201370.","journal-title":"Oncol Rep"},{"issue":"1\u20132","key":"11_CR92","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","volume":"647","author":"JA Simon","year":"2008","unstructured":"Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res. 2008;647(1\u20132):21\u20139.","journal-title":"Mutat Res"},{"issue":"2","key":"11_CR93","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000356679","volume":"33","author":"W Pan","year":"2014","unstructured":"Pan W, Wang H, Jianwei R, Ye Z. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem. 2014;33(2):402\u201312.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"11_CR94","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3892\/mmr.2014.2582","volume":"10","author":"H Lv","year":"2014","unstructured":"Lv H, Pei J, Liu H, Wang H, Liu J. A polymorphism site in the premiR34a coding region reduces miR34a expression and promotes osteosarcoma cell proliferation and migration. Mol Med Rep. 2014;10(6):2912\u20136.","journal-title":"Mol Med Rep"},{"issue":"5","key":"11_CR95","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1007\/s13277-014-1637-2","volume":"35","author":"J Wang","year":"2014","unstructured":"Wang J, Xu G, Shen F, Kang Y. miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumour Biol. 2014;35(5):4859\u201365.","journal-title":"Tumour Biol"},{"issue":"6","key":"11_CR96","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3892\/ijmm.2014.1963","volume":"34","author":"M Zhao","year":"2014","unstructured":"Zhao M, Huang J, Gui K, Xiong M, Cai G, Xu J, et al. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression. Int J Mol Med. 2014;34(6):1565\u201372.","journal-title":"Int J Mol Med"},{"issue":"5","key":"11_CR97","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3892\/ijmm.2012.1111","volume":"30","author":"H Zhao","year":"2012","unstructured":"Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X, et al. miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. Int J Mol Med. 2012;30(5):1013\u201320.","journal-title":"Int J Mol Med"},{"issue":"10","key":"11_CR98","doi-asserted-by":"publisher","first-page":"e109138","DOI":"10.1371\/journal.pone.0109138","volume":"9","author":"L Shen","year":"2014","unstructured":"Shen L, Wang P, Yang J, Li X. MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma. PLoS One. 2014;9(10):e109138.","journal-title":"PLoS One"},{"key":"11_CR99","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0074-7696(03)29006-9","volume":"229","author":"S Suetsugu","year":"2003","unstructured":"Suetsugu S, Takenawa T. Regulation of cortical actin networks in cell migration. Int Rev Cytol. 2003;229:245\u201386.","journal-title":"Int Rev Cytol"},{"issue":"2","key":"11_CR100","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/pbc.24763","volume":"61","author":"Z Wang","year":"2014","unstructured":"Wang Z, Cai H, Lin L, Tang M. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Pediatr Blood Cancer. 2014;61(2):206\u201310.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"11_CR101","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.3892\/mmr.2014.2616","volume":"10","author":"X Wang","year":"2014","unstructured":"Wang X, Sun J, Fu C, Wang D, Bi Z. MicroRNA-214 regulates osteosarcoma survival and growth by directly targeting phosphatase and tensin homolog. Mol Med Rep. 2014;10(6):3073\u20139.","journal-title":"Mol Med Rep"},{"issue":"3","key":"11_CR102","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ijc.25715","volume":"129","author":"A Gougelet","year":"2011","unstructured":"Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, Dutour A, et al. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer. 2011;129(3):680\u201390.","journal-title":"Int J Cancer"},{"issue":"46","key":"11_CR103","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1038\/onc.2009.274","volume":"28","author":"B Song","year":"2009","unstructured":"Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene. 2009;28(46):4065\u201374.","journal-title":"Oncogene"},{"issue":"7","key":"11_CR104","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1007\/s13277-014-1965-2","volume":"35","author":"S Guo","year":"2014","unstructured":"Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang Y, et al. miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy. Tumour Biol. 2014;35(7):7025\u201334.","journal-title":"Tumour Biol"},{"issue":"8","key":"11_CR105","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1593\/neo.07367","volume":"9","author":"N Entz-Werle","year":"2007","unstructured":"Entz-Werle N, Lavaux T, Metzger N, Stoetzel C, Lasthaus C, Marec P, et al. Involvement of MET\/TWIST\/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis. Neoplasia. 2007;9(8):678\u201388.","journal-title":"Neoplasia"},{"issue":"3","key":"11_CR106","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3892\/ol.2013.1111","volume":"5","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Zang X, Huang Z, Zhang C. TWIST interacts with endothelin-1\/endothelin A receptor signaling in osteosarcoma cell survival against cisplatin. Oncol Lett. 2013;5(3):857\u201361.","journal-title":"Oncol Lett"},{"issue":"6","key":"11_CR107","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/mc.21991","volume":"53","author":"J Wu","year":"2014","unstructured":"Wu J, Liao Q, He H, Zhong D, Yin K. TWIST interacts with beta-catenin signaling on osteosarcoma cell survival against cisplatin. Mol Carcinog. 2014;53(6):440\u20136.","journal-title":"Mol Carcinog"},{"key":"11_CR108","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-9966-33-12","volume":"33","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Huang Z, Wu S, Zang X, Liu M, Shi J. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. J Exp Clin Cancer Res. 2014;33:12.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"11_CR109","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12032-013-0821-3","volume":"31","author":"Y Mu","year":"2014","unstructured":"Mu Y, Zhang H, Che L, Li K. Clinical significance of microRNA-183\/Ezrin axis in judging the prognosis of patients with osteosarcoma. Med Oncol. 2014;31(2):821.","journal-title":"Med Oncol"},{"key":"11_CR110","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-1172-8-7","volume":"8","author":"AL Sarver","year":"2013","unstructured":"Sarver AL, Thayanithy V, Scott MC, Cleton-Jansen AM, Hogendoorn PC, Modiano JF, et al. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma. Orphanet J Rare Dis. 2013;8:7.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"11_CR111","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/gm406","volume":"5","author":"AD Kelly","year":"2013","unstructured":"Kelly AD, Haibe-Kains B, Janeway KA, Hill KE, Howe E, Goldsmith J, et al. MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32. Genome Med. 2013;5(1):2.","journal-title":"Genome Med"},{"issue":"5","key":"11_CR112","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/path.3007","volume":"226","author":"F Nakatani","year":"2012","unstructured":"Nakatani F, Ferracin M, Manara MC, Ventura S, Del Monaco V, Ferrari S, et al. miR-34a predicts survival of Ewing\u2019s sarcoma patients and directly influences cell chemo-sensitivity and malignancy. J Pathol. 2012;226(5):796\u2013805.","journal-title":"J Pathol"},{"issue":"3","key":"11_CR113","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/SLA.0b013e3181cc939f","volume":"251","author":"HM Heneghan","year":"2010","unstructured":"Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg. 2010;251(3):499\u2013505.","journal-title":"Ann Surg"},{"issue":"8","key":"11_CR114","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/jso.23174","volume":"106","author":"M Nugent","year":"2012","unstructured":"Nugent M, Miller N, Kerin MJ. Circulating miR-34a levels are reduced in colorectal cancer. J Surg Oncol. 2012;106(8):947\u201352.","journal-title":"J Surg Oncol"},{"issue":"10","key":"11_CR115","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997\u20131006.","journal-title":"Cell Res"},{"issue":"30","key":"11_CR116","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"11_CR117","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1177\/030006051204000606","volume":"40","author":"J Yuan","year":"2012","unstructured":"Yuan J, Chen L, Chen X, Sun W, Zhou X. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma. J Int Med Res. 2012;40(6):2090\u20137.","journal-title":"J Int Med Res"},{"issue":"4","key":"11_CR118","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.3390\/ijms15046544","volume":"15","author":"C Zhang","year":"2014","unstructured":"Zhang C, Yao C, Li H, Wang G, He X. Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas. Int J Mol Sci. 2014;15(4):6544\u201355.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"11_CR119","first-page":"4194","volume":"7","author":"C Zhang","year":"2014","unstructured":"Zhang C, Yao C, Li H, Wang G, He X. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. Int J Clin Exp Pathol. 2014;7(7):4194\u2013203.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"11_CR120","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/pbc.23040","volume":"57","author":"M Stahl","year":"2011","unstructured":"Stahl M, Ranft A, Paulussen M, Bolling T, Vieth V, Bielack S, et al. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Pediatr Blood Cancer. 2011;57(4):549\u201353.","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"11_CR121","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2106\/JBJS.L.00955","volume":"94","author":"JH Schwab","year":"2012","unstructured":"Schwab JH, Springfield DS, Raskin KA, Mankin HJ, Hornicek FJ. What\u2019s new in primary bone tumors. J Bone Joint Surg Am. 2012;94(20):1913\u20139.","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"11_CR122","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/ng0294-146","volume":"6","author":"PH Sorensen","year":"1994","unstructured":"Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. A second Ewing\u2019s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor. ERG Nat Genet. 1994;6(2):146\u201351.","journal-title":"ERG Nat Genet"},{"issue":"6","key":"11_CR123","first-page":"1229","volume":"10","author":"IS Jeon","year":"1995","unstructured":"Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, et al. A variant Ewing\u2019s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 1995;10(6):1229\u201334.","journal-title":"Oncogene"},{"issue":"1","key":"11_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2006.12.009","volume":"254","author":"N Riggi","year":"2007","unstructured":"Riggi N, Stamenkovic I. The biology of Ewing sarcoma. Cancer Lett. 2007;254(1):1\u201310.","journal-title":"Cancer Lett"},{"issue":"1","key":"11_CR125","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/gm129","volume":"2","author":"H Kovar","year":"2010","unstructured":"Kovar H. Downstream EWS\/FLI1\u2014upstream Ewing\u2019s sarcoma. Genome Med. 2010;2(1):8.","journal-title":"Genome Med"},{"issue":"23","key":"11_CR126","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1158\/0008-5472.CAN-09-1540","volume":"69","author":"M Kinsey","year":"2009","unstructured":"Kinsey M, Smith R, Iyer AK, McCabe ER, Lessnick SL. EWS\/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing\u2019s sarcoma. Cancer Res. 2009;69(23):9047\u201355.","journal-title":"Cancer Res"},{"issue":"8","key":"11_CR127","doi-asserted-by":"publisher","first-page":"e23592","DOI":"10.1371\/journal.pone.0023592","volume":"6","author":"C De Vito","year":"2011","unstructured":"De Vito C, Riggi N, Suva ML, Janiszewska M, Horlbeck J, Baumer K, et al. Let-7a is a direct EWS-FLI-1 target implicated in Ewing\u2019s sarcoma development. PLoS One. 2011;6(8):e23592.","journal-title":"PLoS One"},{"issue":"2","key":"11_CR128","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/onc.2013.541","volume":"34","author":"JK Parrish","year":"2013","unstructured":"Parrish JK, Sechler M, Winn RA, Jedlicka P. The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma. Oncogene. 2013;34(2):257\u201362.","journal-title":"Oncogene"},{"issue":"3","key":"11_CR129","doi-asserted-by":"publisher","first-page":"e93067","DOI":"10.1371\/journal.pone.0093067","volume":"9","author":"B Karnuth","year":"2014","unstructured":"Karnuth B, Dedy N, Spieker T, Lawlor ER, Gattenlohner S, Ranft A, et al. Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion. PLoS One. 2014;9(3):e93067.","journal-title":"PLoS One"},{"issue":"10","key":"11_CR130","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/annonc\/mdu249","volume":"25","author":"MT Marino","year":"2014","unstructured":"Marino MT, Grilli A, Baricordi C, Manara MC, Ventura S, Pinca RS, et al. Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression. Ann Oncol. 2014;25(10):2080\u20136.","journal-title":"Ann Oncol"},{"issue":"1","key":"11_CR131","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajpath.2013.03.001","volume":"183","author":"RG Pestell","year":"2013","unstructured":"Pestell RG. New roles of cyclin D1. Am J Pathol. 2013;183(1):3\u20139.","journal-title":"Am J Pathol"},{"issue":"2","key":"11_CR132","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/cpr.12093","volume":"47","author":"J Li","year":"2014","unstructured":"Li J, You T, Jing J. MiR-125b inhibits cell biological progression of Ewing\u2019s sarcoma by suppressing the PI3K\/Akt signalling pathway. Cell Prolif. 2014;47(2):152\u201360.","journal-title":"Cell Prolif"},{"issue":"18","key":"11_CR133","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/onc.2010.581","volume":"30","author":"J Ban","year":"2011","unstructured":"Ban J, Jug G, Mestdagh P, Schwentner R, Kauer M, Aryee DN, et al. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing\u2019s sarcoma. Oncogene. 2011;30(18):2173\u201380.","journal-title":"Oncogene"},{"issue":"8","key":"11_CR134","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/1541-7786.MCR-12-0086","volume":"10","author":"TP Robin","year":"2012","unstructured":"Robin TP, Smith A, McKinsey E, Reaves L, Jedlicka P, Ford HL. EWS\/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. Mol Cancer Res. 2012;10(8):1098\u2013108.","journal-title":"Mol Cancer Res"},{"issue":"33","key":"11_CR135","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1038\/onc.2012.403","volume":"32","author":"GA Franzetti","year":"2013","unstructured":"Franzetti GA, Laud-Duval K, Bellanger D, Stern MH, Sastre-Garau X, Delattre O. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor. Oncogene. 2013;32(33):3915\u201321.","journal-title":"Oncogene"},{"issue":"9","key":"11_CR136","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1101\/gad.1899710","volume":"24","author":"N Riggi","year":"2010","unstructured":"Riggi N, Suva ML, De Vito C, Provero P, Stehle JC, Baumer K, et al. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev. 2010;24(9):916\u201332.","journal-title":"Genes Dev"},{"key":"11_CR137","doi-asserted-by":"publisher","first-page":"932451","DOI":"10.1155\/2011\/932451","volume":"2011","author":"E David","year":"2011","unstructured":"David E, Blanchard F, Heymann MF, De Pinieux G, Gouin F, Redini F, et al. The bone niche of chondrosarcoma: a sanctuary for drug resistance, tumour growth and also a source of new therapeutic targets. Sarcoma. 2011;2011:932451.","journal-title":"Sarcoma"},{"key":"11_CR138","doi-asserted-by":"publisher","first-page":"381564","DOI":"10.1155\/2011\/381564","volume":"2011","author":"AC Onishi","year":"2011","unstructured":"Onishi AC, Hincker AM, Lee FY. Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets. Sarcoma. 2011;2011:381564.","journal-title":"Sarcoma"},{"issue":"12","key":"11_CR139","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/jor.22457","volume":"31","author":"T Yoshitaka","year":"2013","unstructured":"Yoshitaka T, Kawai A, Miyaki S, Numoto K, Kikuta K, Ozaki T, et al. Analysis of microRNAs expressions in chondrosarcoma. J Orthop Res. 2013;31(12):1992\u20138.","journal-title":"J Orthop Res"},{"issue":"2","key":"11_CR140","doi-asserted-by":"publisher","first-page":"917","DOI":"10.7314\/APJCP.2014.15.2.917","volume":"15","author":"Z Zhu","year":"2014","unstructured":"Zhu Z, Wang CP, Zhang YF, Nie L. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR. Asian Pac J Cancer Prev. 2014;15(2):917\u201323.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"11_CR141","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.canlet.2014.11.015","volume":"357","author":"G Liu","year":"2014","unstructured":"Liu G, Huang Y, Tzeng H, Tsai C, Wang S, Tang C. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells. Cancer Lett. 2014;357(2):476\u201387.","journal-title":"Cancer Lett"},{"issue":"1","key":"11_CR142","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/ijo.2013.2155","volume":"44","author":"W Liang","year":"2014","unstructured":"Liang W, Li X, Li Y, Li C, Gao B, Gan H, et al. Gallic acid induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 human chondrosarcoma cells. Int J Oncol. 2014;44(1):91\u20138.","journal-title":"Int J Oncol"},{"issue":"3","key":"11_CR143","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s13277-013-1309-7","volume":"35","author":"KA Galoian","year":"2013","unstructured":"Galoian KA, Guettouche T, Issac B, Qureshi A, Temple HT. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma. Tumour Biol. 2013;35(3):2335\u201341.","journal-title":"Tumour Biol"},{"issue":"7","key":"11_CR144","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2106\/00004623-199407000-00005","volume":"76","author":"GA Schmale","year":"1994","unstructured":"Schmale GA, Conrad 3rd EU, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 1994;76(7):986\u201392.","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"11_CR145","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1399-0004.2010.01490.x","volume":"78","author":"M Zuntini","year":"2010","unstructured":"Zuntini M, Salvatore M, Pedrini E, Parra A, Sgariglia F, Magrelli A, et al. MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures. Clin Genet. 2010;78(6):507\u201316.","journal-title":"Clin Genet"},{"issue":"2","key":"11_CR146","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5435\/JAAOS-21-02-118","volume":"21","author":"KA Raskin","year":"2013","unstructured":"Raskin KA, Schwab JH, Mankin HJ, Springfield DS, Hornicek FJ. Giant cell tumor of bone. J Am Acad Orthop Surg. 2013;21(2):118\u201326.","journal-title":"J Am Acad Orthop Surg"},{"key":"11_CR147","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/BLO.0b013e31804856a1","volume":"459","author":"M Ghert","year":"2007","unstructured":"Ghert M, Simunovic N, Cowan RW, Colterjohn N, Singh G. Properties of the stromal cell in giant cell tumor of bone. Clin Orthop Relat Res. 2007;459:8\u201313.","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"11_CR148","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bone.2009.01.393","volume":"44","author":"RW Cowan","year":"2009","unstructured":"Cowan RW, Mak IW, Colterjohn N, Singh G, Ghert M. Collagenase expression and activity in the stromal cells from giant cell tumour of bone. Bone. 2009;44(5):865\u201371.","journal-title":"Bone"},{"issue":"2","key":"11_CR149","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.bone.2009.04.253","volume":"45","author":"IW Mak","year":"2009","unstructured":"Mak IW, Cowan RW, Popovic S, Colterjohn N, Singh G, Ghert M. Upregulation of MMP-13 via Runx2 in the stromal cell of giant cell tumor of bone. Bone. 2009;45(2):377\u201386.","journal-title":"Bone"},{"issue":"5","key":"11_CR150","first-page":"671","volume":"28","author":"N Mosakhani","year":"2013","unstructured":"Mosakhani N, Pazzaglia L, Benassi MS, Borze I, Quattrini I, Picci P, et al. MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone. Histol Histopathol. 2013;28(5):671\u20138.","journal-title":"Histol Histopathol"},{"issue":"3","key":"11_CR151","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.bbrc.2013.12.075","volume":"443","author":"Z Wu","year":"2014","unstructured":"Wu Z, Yin H, Liu T, Yan W, Li Z, Chen J, et al. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13. Biochem Biophys Res Commun. 2014;443(3):944\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"11_CR152","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/1471-2407-14-495","volume":"14","author":"B Lehner","year":"2014","unstructured":"Lehner B, Kunz P, Saehr H, Fellenberg J. Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone. BMC Cancer. 2014;14:495.","journal-title":"BMC Cancer"},{"issue":"7163","key":"11_CR153","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature06174","volume":"449","author":"L Ma","year":"2007","unstructured":"Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449(7163):682\u20138.","journal-title":"Nature"},{"issue":"36","key":"11_CR154","doi-asserted-by":"publisher","first-page":"13556","DOI":"10.1073\/pnas.0803055105","volume":"105","author":"A Lujambio","year":"2008","unstructured":"Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A. 2008;105(36):13556\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"11_CR155","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbrc.2012.07.025","volume":"425","author":"L Huang","year":"2012","unstructured":"Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, et al. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun. 2012;425(2):127\u201333.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"11_CR156","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1158\/1541-7786.MCR-13-0136","volume":"12","author":"M Gong","year":"2014","unstructured":"Gong M, Ma J, Guillemette R, Zhou M, Yang Y, Hock JM, et al. miR-335 inhibits small cell lung cancer bone metastases via IGF-1R and RANKL pathways. Mol Cancer Res. 2014;12(1):101\u201310.","journal-title":"Mol Cancer Res"},{"issue":"6","key":"11_CR157","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1016\/j.bbagen.2013.02.022","volume":"1830","author":"PL Kuo","year":"2013","unstructured":"Kuo PL, Liao SH, Hung JY, Huang MS, Hsu YL. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta. 2013;1830(6):3756\u201366.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"11_CR158","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/jcb.24502","volume":"114","author":"W Guo","year":"2013","unstructured":"Guo W, Ren D, Chen X, Tu X, Huang S, Wang M, et al. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145. J Cell Biochem. 2013;114(7):1606\u201315.","journal-title":"J Cell Biochem"},{"issue":"5","key":"11_CR159","doi-asserted-by":"publisher","first-page":"e20341","DOI":"10.1371\/journal.pone.0020341","volume":"6","author":"X Peng","year":"2011","unstructured":"Peng X, Guo W, Liu T, Wang X, Tu X, Xiong D, et al. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One. 2011;6(5):e20341.","journal-title":"PLoS One"},{"issue":"16","key":"11_CR160","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1158\/1078-0432.CCR-10-2619","volume":"17","author":"S Saini","year":"2011","unstructured":"Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, et al. Regulatory role of mir-203 in prostate cancer progression and metastasis. Clin Cancer Res. 2011;17(16):5287\u201398.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"11_CR161","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.4161\/cc.10.7.15180","volume":"10","author":"G Viticchie","year":"2011","unstructured":"Viticchie G, Lena AM, Latina A, Formosa A, Gregersen LH, Lund AH, et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle. 2011;10(7):1121\u201331.","journal-title":"Cell Cycle"},{"issue":"5","key":"11_CR162","doi-asserted-by":"publisher","first-page":"e64393","DOI":"10.1371\/journal.pone.0064393","volume":"8","author":"W Meng","year":"2013","unstructured":"Meng W, McElroy JP, Volinia S, Palatini J, Warner S, Ayers LW, et al. Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. PLoS One. 2013;8(5):e64393.","journal-title":"PLoS One"},{"key":"11_CR163","doi-asserted-by":"crossref","unstructured":"Xiao F, Chen J, Lian C, Han P, Zhang C. Tumor necrosis factor related apoptosis inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements. Mol Med Rep. 2015;11(1):739\u201345.","DOI":"10.3892\/mmr.2014.2710"}],"container-title":["Advances in Experimental Medicine and Biology","microRNA: Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-23730-5_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:08:35Z","timestamp":1718237315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-23730-5_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319237299","9783319237305"],"references-count":163,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-23730-5_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}